Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug–drug interactions involving antidepressants: focus on desvenlafaxine
Yvette M. Low, Sajita Setia, Graça Lima
Neuropsychiatric Disease and Treatment (2018) Vol. Volume 14, pp. 567-580
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study
Jessica Barbut Siva, Tommaso Barba, Hannes Kettner, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 2, pp. 145-155
Open Access | Times Cited: 11
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Yaser Pashaei
Journal of Clinical Neuroscience (2021) Vol. 88, pp. 163-172
Open Access | Times Cited: 43
The treatment of depression — searching for new ideas
Katarzyna Stachowicz, Magdalena Sowa-Kućma
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey
Ebuwa Igho-Osagie, Kaylen Brzozowski, Harry Jin, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 5, pp. 390-399.e4
Open Access | Times Cited: 14
The risk of developing depression in tuberculosis survivors: a nationwide cohort study in South Korea
Hyun Soo Kim, Jin‐Hyung Jung, Kyungdo Han, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
The Effectiveness of Reminiscence Interventions on Depression and Depressive Symptoms in Community-dwelling Older Adults without Significant Cognitive Impairment: A Systematic Review
Yuxuan Yang, Hongfei Li, Xiaomei Cong, et al.
Western Journal of Nursing Research (2025)
Closed Access
The Role of Neuroinflammation in the Comorbidity of Psychiatric Disorders and Internal Diseases
Grecu Ramona Cătălina, Victor Gheorman, Veronica Gheorman, et al.
Healthcare (2025) Vol. 13, Iss. 7, pp. 837-837
Open Access
Depression, Angststörungen, bipolare Störung, Schizophrenie, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung
Johanna Seifert, Stefan Bleich, Roland Seifert
Springer eBooks (2025), pp. 485-535
Closed Access
Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
Kelly Bleasby, Robert Houle, Michael J. Hafey, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1566-1566
Open Access | Times Cited: 22
Involvement of oxidative pathways and BDNF in the antidepressant effect of carvedilol in a depression model induced by chronic unpredictable stress
Caren Nádia Soares de Sousa, Ingridy da Silva Medeiros, Germana Silva Vasconcelos, et al.
Psychopharmacology (2022) Vol. 239, Iss. 1, pp. 297-311
Closed Access | Times Cited: 14
Optimizing human performance in extreme environments through precision medicine: From spaceflight to high-performance operations on Earth
Michael A. Schmidt, Jeffrey A. Jones, Christopher E. Mason
Cambridge Prisms Precision Medicine (2023) Vol. 1
Open Access | Times Cited: 8
Black Cohosh Interactions with Prescription Medications Associated with Serotonin Toxicity and Rhabdomyolysis: A Case Report
Matthew Robert Dernbach, Joseph Carpenter, Nihar Shah, et al.
Journal of Emergency Medicine (2024) Vol. 66, Iss. 5, pp. e592-e596
Closed Access | Times Cited: 2
Desvenlafaxine in the treatment of major depression: an updated overview
Trevor R. Norman, James Olver
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 9, pp. 1087-1097
Closed Access | Times Cited: 15
Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021
Cvetka Bačar Bole, Katja Nagode, Mitja Pišlar, et al.
Medicina (2023) Vol. 59, Iss. 2, pp. 284-284
Open Access | Times Cited: 6
A fatal case of desvenlafaxine and paroxetine poisoning
Su-Jin Jeong, Yoseob Kim, Sanggil Choe, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116148-116148
Closed Access | Times Cited: 1
Empagliflozin ameliorates olfactory bulbectomy-induced depression by mitigating oxidative stress and possible involvement of brain derived neurotrophic factor in diabetic rats
Sachin P. Borikar, Gaurav V. Chitode, Deepali N. Tapre, et al.
International Journal of Neuroscience (2024), pp. 1-17
Closed Access | Times Cited: 1
Reproductive Toxicity Induced by Serotonin‐Norepinephrine Reuptake Inhibitors: A Pharmacovigilance Analysis From 2004 to 2023 Based on the FAERS Database
Yujia Xi, Zhi Bao, Qiang Guo, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 12
Open Access | Times Cited: 1
Potential drug-drug interactions in outpatients with depression of a psychiatry department
Yang Chen, Lijun Ding
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 2, pp. 207-213
Open Access | Times Cited: 7
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper
Fernando Barata, Carlos Aguíar, Tiago Reis Marques, et al.
Drug Safety (2021) Vol. 44, Iss. 8, pp. 825-834
Closed Access | Times Cited: 8
The Depressed Heart
Seth W. Perry, Júlio Licinio, Ma‐Li Wong
Heart and Mind (2019) Vol. 3, Iss. 2, pp. 35-46
Open Access | Times Cited: 7
<p>Effects of Dexmedetomidine on the Pharmacokinetics of Dezocine, Midazolam and Its Metabolite 1-Hydroxymidazolam in Beagles by UPLC-MS/MS</p>
Wei Zhou, Shuang-long Li, Ti Zhao, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 2595-2605
Open Access | Times Cited: 6
Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper
Gaia Sampogna, Filippo Caraci, Claudia Carmassi, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 14, pp. 1511-1525
Closed Access | Times Cited: 2
Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis
Jorge A. Sánchez-Ruiz, Nicole I. Leibman, Nicholas B. Larson, et al.
Journal of Women s Health (2023) Vol. 32, Iss. 11, pp. 1229-1240
Closed Access | Times Cited: 2
Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism
Nicola Ferri, Sara De Martin, James D. Stuart, et al.
Drugs in R&D (2023) Vol. 24, Iss. 1, pp. 51-68
Open Access | Times Cited: 2
The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential
Mohamed H. Al-Sabri, Maryam Nikpour, Laura E. Clemensson, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top